• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    58 Biggest Movers From Yesterday

    5/24/22 5:29:12 AM ET
    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $ADGI alert in real time by email

    Gainers

    • Catalyst Biosciences, Inc. (NASDAQ:CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) surged 66.9% to settle at $2.32 after Maxim Group reiterated a Buy rating on the stock and announced a $6 price target.
    • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) rose 58% to settle at $3.16.
    • View, Inc. (NASDAQ:VIEW) gained 43.4% to close at $0.9765.
    • Predictive Oncology Inc. (NASDAQ:POAI) gained 40.7% to close at $0.38. Predictive Oncology recently reported closing of $7.2 million registered direct offerings.
    • Standard BioTools Inc. (NASDAQ:LAB) surged 33.3% to close at $2.60.
    • Evolve Transition Infrastructure LP (NYSE:SNMP) shares jumped 32.8% to close at $0.6889 on Monday after jumping around 14% on Friday.
    • Neonode Inc. (NASDAQ:NEON) jumped 28.8% to settle at $5.59. Neonode recently posted a Q1 loss of $0.10 per share.
    • O2Micro International Limited (NASDAQ:OIIM) shares climbed 28.6% to close at $3.78. O2Micro announced the receipt of an updated preliminary non-binding proposal to acquire the company.
    • Sonder Holdings Inc. (NASDAQ:SOND) gained 27.4% to settle at $2.23.
    • Mesa Royalty Trust (NYSE:MTR) jumped 25.8% to close at $18.38.
    • GoldMining Inc. (NYSE:GLDG) surged 25% to settle at $1.35.
    • VMware, Inc. (NYSE:VMW) rose 24.8% to close at $119.43 following several reports Broadcom is in talks to acquire the company.
    • Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) gained 24.4% to close at $2.86.
    • Aethlon Medical, Inc. (NASDAQ:AEMD) surged 22.9% to close at $1.61.
    • Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) jumped 22.5% to close at $0.95.
    • United-Guardian, Inc. (NASDAQ:UG) jumped 22% to close at $20.00. United-Guardian recently posted Q1 EPS of $0.20.
    • Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) jumped 21.1% to settle at $2.18 after Innoviva announced it will acquire the company for $2.20 per share.
    • BIOLASE, Inc. (NASDAQ:BIOL) jumped 19.9% to settle at $5.12.
    • Forge Global Holdings, Inc. (NYSE:FRGE) shares gained 18.9% to close at $21.05 after dipping 15% on Friday.
    • Troika Media Group, Inc. (NASDAQ:TRKA) rose 18.4% to close at $0.7908.
    • Bright Green Corporation (NASDAQ:BGXX) gained 18% to close at $13.28 after dropping around 28% on Friday.
    • Nerdy, Inc. (NYSE:NRDY) surged 18% to close at $2.10.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) jumped 16.1% to close at $2.38 after climbing 25% on Friday.
    • Rallybio Corporation (NASDAQ:RLYB) gained 15% to close at $12.66.
    • BTCS Inc. (NASDAQ:BTCS) jumped 14.4% to settle at $2.70.
    • Origin Agritech Limited (NASDAQ:SEED) climbed 14.3% to close at $7.44. Origin Agritech received order for 20,000 metric tons of nutritionally enhanced corn.
    • TreeHouse Foods, Inc. (NYSE:THS) gained 11.7% to settle at $40.98. Truist Securities upgraded Treehouse Foods from Hold to Buy and raised the price target from $35 to $50.
    • Repare Therapeutics Inc. (NASDAQ:RPTX) rose 10.3% to close at $9.32. Repare Therapeutics recently posted a Q1 loss of $0.83 per share.
    • SurgePays, Inc. (NASDAQ:SURG) climbed 9% to close at $4.83. Surgepays recently posted a Q1 loss of $0.10 per share.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) gained 8.5% to close at $5.77 after jumping 40% on Friday.
    • American Axle & Manufacturing Holdings, Inc. (NYSE:AXL) gained 6.8% to close at $7.21. American Axle is exploring a sale, Bloomberg reported.


    Losers

    • Nymox Pharmaceutical Corporation (NASDAQ:NYMX) tumbled 63.9% to close at $0.4555 on Monday after the company received a Refusal to File letter from the FDA regarding the company's New Drug Application for fexapotide triflutate.
    • Inotiv, Inc. (NASDAQ:NOTV) dipped 28.3% to close at $13.14. Inotiv said on May 18, U.S. Department of Justice executed a search and seizure warrant on Cumberland, Virginia facility.
    • Liquidia Corporation (NASDAQ:LQDA) dropped 18.8% to settle at $4.70. Liquidia Technologies recently posted a Q1 loss of $0.30 per share.
    • EBET, Inc. (NASDAQ:EBET) fell 18.2% to settle at $3.15.
    • Athersys, Inc. (NASDAQ:ATHX) declined 17.9% to close at $0.2140. B of A Securities downgraded Athersys from Neutral to Underperform and lowered the price target from $1 to $0.25.
    • TherapeuticsMD, Inc. (NASDAQ:TXMD) dipped 17.4% to close at $2.56. TherapeuticsMD shares gained around 37% on Friday after the company announced that it has received FDA approval of its supplemental New Drug Application for ANNOVERA.
    • Tiziana Life Sciences PLC (NASDAQ:TLSA) declined 17.4% to settle at $0.7107.
    • Harpoon Therapeutics, Inc. (NASDAQ:HARP) fell 16.1% to settle at $2.14.
    • ShiftPixy, Inc. (NASDAQ:PIXY) shares slipped 16.1% to close at $0.3526.
    • Performance Shipping Inc. (NASDAQ:PSHG) dropped 16% to close at $2.36.
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) fell 15.5% to close at $1.86.
    • NanoViricides, Inc. (NYSE:NNVC) dipped 15% to close at $2.21 after jumping around 40% on Friday.
    • Endo International plc (NASDAQ:ENDP) fell 14.9% to settle at $0.3957.
    • Farmmi, Inc. (NASDAQ:FAMI) dropped 14.6% to settle at $0.0665. Farmmi Monday received determination from Nasdaq to delist the company's securities from The Nasdaq Capital Market because the company's securities have had a closing bid price below $0.10 for ten consecutive trading days.
    • Avaya Holdings Corp. (NYSE:AVYA) declined 14.4% to close at $4.11.
    • Foghorn Therapeutics Inc. (NASDAQ:FHTX) fell 12.4% to close at $11.84. Morgan Stanley maintained Foghorn Therapeutics with an Overweight and lowered the price target from $26 to $25.
    • Evoke Pharma, Inc. (NASDAQ:EVOK) shares fell 11.5% to close at $2.72 after effect of 1:12 reverse stock split.
    • Nordic American Tankers Limited (NYSE:NAT) dipped 11.2% to close at $2.37.
    • Carvana Co. (NYSE:CVNA) fell 9.9% to close at $30.24.
    • ATRenew Inc. (NYSE:RERE) fell 9.6% to close at $2.73.
    • Adagio Therapeutics, Inc. (NASDAQ:ADGI) fell 9.5% to close at $2.67.
    • Leju Holdings Limited (NYSE:LEJU) slipped 8.3% to settle at $4.45 after climbing over 53% on Friday.
    • CareDx, Inc (NASDAQ:CDNA) fell 7.5% to close at $23.92. CareDx said its CFO Ankur Dhingra notified the company of his intent to resign effective as of end of day on May 25, 2022.
    • PowerSchool Holdings, Inc. (NYSE:PWSC) fell 5.7% to close at $12.31. The company recently posted downbeat quarterly earnings.
    • The Gap, Inc. (NYSE:GPS) tumbled 5.5% to close at $10.33. Citigroup downgraded Gap from Neutral to Sell and lowered the price target from $13 to $8.
    • XPeng Inc. (NYSE:XPEV) fell 5.5% to close at $21.98 after the company reported Q1 financial results.
    Get the next $ADGI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADGI
    $AEMD
    $ALLR
    $ATHX

    CompanyDatePrice TargetRatingAnalyst
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Foghorn Therapeutics Inc.
    $FHTX
    2/17/2026$12.00Buy
    Jefferies
    Crescent Biopharma Inc.
    $CBIO
    1/28/2026$35.00Overweight
    Piper Sandler
    American Axle & Manufacturing Holdings Inc.
    $AXL
    1/27/2026$17.00Buy
    BWS Financial
    Crescent Biopharma Inc.
    $CBIO
    1/21/2026$35.00Buy
    Guggenheim
    CareDx Inc.
    $CDNA
    1/6/2026$26.00Buy → Hold
    Craig Hallum
    Foghorn Therapeutics Inc.
    $FHTX
    12/18/2025$11.00Buy
    BTIG Research
    NanoViricides Inc.
    $NNVC
    12/16/2025Buy
    Alliance Global Partners
    More analyst ratings

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Tentative Approval for YUTREPIA issued to Liquidia Technologies, Inc.

    Submission status for Liquidia Technologies, Inc.'s drug YUTREPIA (ORIG-1) with active ingredient TREPROSTINIL has changed to 'Tentative Approval' on 11/04/2021. Application Category: NDA, Application Number: 213005, Application Classification: Type 3 - New Dosage Form

    11/18/21 2:49:33 PM ET
    $LQDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug IMVEXXY (SUPPL-2) with active ingredient ESTRADIOL has changed to 'Approval' on 11/16/2021. Application Category: NDA, Application Number: 208564, Application Classification: Labeling

    11/17/21 4:38:32 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    CareDx, Inc. (NASDAQ:CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the award of inducement grants. On February 24, 2026, as an inducement material to acceptance of employment with CareDx, 35 new employees were awarded restricted stock units (RSUs) for an aggregate of 82,137 shares of common stock. The RSU awards were made pursuant to the Company's 2016 and 2025 Inducement Equity Incentive Plans in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, wit

    2/27/26 4:01:00 PM ET
    $CDNA
    Medical Specialities
    Health Care

    Carvana to Present at Upcoming Morgan Stanley Technology, Media & Telecom Conference

    Carvana (NYSE:CVNA), a leading e-commerce platform for buying and selling cars, today announced that Ernie Garcia, Carvana's Founder and Chief Executive Officer, will present to the investor community and host meetings at the upcoming Morgan Stanley Technology, Media & Telecom Conference. Morgan Stanley Technology, Media & Telecom Conference Presentation Date and Time: Monday, March 2, 2026, at 12:20 PM PT* *A webcast of the presentation will be accessible on the Investor Relations section of the Carvana website (https://investors.carvana.com). An archived replay of the webcast will be available following the live presentation. About Carvana Carvana's mission is to change the way pe

    2/27/26 8:00:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Nerdy Announces Fourth Quarter 2025 Financial Results

    Nerdy returns to year-over-year revenue growth and delivers positive non-GAAP Adjusted EBITDA in Q4 2025, beating guidance on both metrics and demonstrating significant improvement in the Company's cost structure. Nerdy completes replatforming and launch of its Live+AI™ platform using AI-native coding during the fourth quarter, providing the Company with significant momentum as we enter 2026. Nerdy Inc. (NYSE:NRDY) today announced financial results for the fourth quarter and year ended December 31, 2025. "In the fourth quarter, we returned to year-over-year revenue growth and delivered positive non-GAAP adjusted EBITDA, beating the top end of our guidance range for both metrics. We dr

    2/26/26 4:01:00 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Silver Point Capital L.P. bought $8,783,283 worth of shares (357,917 units at $24.54) (SEC Form 4)

    4 - TreeHouse Foods, Inc. (0001320695) (Issuer)

    2/12/26 8:35:21 PM ET
    $THS
    Packaged Foods
    Consumer Staples

    Director Thompson Tommy G bought $14,031 worth of shares (8,400 units at $1.67), increasing direct ownership by 57% to 23,179 units (SEC Form 4)

    4 - TherapeuticsMD, Inc. (0000025743) (Issuer)

    12/29/25 4:23:31 PM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Cohn Charles K. bought $240,635 worth of shares (197,242 units at $1.22) (SEC Form 4)

    4 - Nerdy Inc. (0001819404) (Issuer)

    12/18/25 9:04:27 AM ET
    $NRDY
    Other Consumer Services
    Real Estate

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Rodriques Kelly covered exercise/tax liability with 1,347 shares, decreasing direct ownership by 0.26% to 522,330 units (SEC Form 4)

    4 - Forge Global Holdings, Inc. (0001827821) (Issuer)

    2/24/26 4:06:43 PM ET
    $FRGE
    Investment Bankers/Brokers/Service
    Finance

    Chief Financial Officer Nevin James covered exercise/tax liability with 133 shares, decreasing direct ownership by 0.19% to 69,204 units (SEC Form 4)

    4 - Forge Global Holdings, Inc. (0001827821) (Issuer)

    2/24/26 4:05:21 PM ET
    $FRGE
    Investment Bankers/Brokers/Service
    Finance

    Chief Accounting Officer Dondzila Catherine M covered exercise/tax liability with 755 shares, decreasing direct ownership by 1% to 55,743 units (SEC Form 4)

    4 - Forge Global Holdings, Inc. (0001827821) (Issuer)

    2/24/26 4:04:19 PM ET
    $FRGE
    Investment Bankers/Brokers/Service
    Finance

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Jefferies resumed coverage on Foghorn Therapeutics with a new price target

    Jefferies resumed coverage of Foghorn Therapeutics with a rating of Buy and set a new price target of $12.00

    2/17/26 7:49:23 AM ET
    $FHTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Piper Sandler initiated coverage on Crescent Biopharma with a new price target

    Piper Sandler initiated coverage of Crescent Biopharma with a rating of Overweight and set a new price target of $35.00

    1/28/26 7:10:21 AM ET
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Rallybio Corporation

    SCHEDULE 13D/A - Rallybio Corp (0001739410) (Subject)

    2/27/26 4:45:52 PM ET
    $RLYB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 40-F filed by GoldMining Inc.

    40-F - GoldMining Inc. (0001538847) (Filer)

    2/27/26 4:39:15 PM ET
    $GLDG
    Precious Metals
    Basic Materials

    SEC Form S-8 filed by Nerdy Inc.

    S-8 - Nerdy Inc. (0001819404) (Filer)

    2/26/26 4:12:06 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Leadership Updates

    Live Leadership Updates

    View All

    CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer

    Kennedy brings seven years of public company CFO experience CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced that Keith Kennedy, the Company's Chief Operating Officer (COO), will also assume the responsibilities of Chief Financial Officer (CFO) and oversee the Company's finance organization effective February 26, 2026. Kennedy brings to CareDx over 20 years of experience and executive leadership in healthcare including global diagnostics, biopharma services, and contrac

    2/24/26 5:15:00 PM ET
    $CDNA
    Medical Specialities
    Health Care

    Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

    Aethlon invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference.SAN DIEGO, Feb. 23, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 25, 2026 at 12:30-1:00 PM ET. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO and CFO, Jim Frakes in

    2/23/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer

    WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (NASDAQ:FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that Ryan Maynard will join the company as Chief Financial Officer (CFO) on February 23, 2026. Mr. Maynard joins Foghorn with over 25 years of executive experience driving financial strategy, capital markets execution, and operational performance across public and private biopharmaceutical companies. "I am delighted to welcome Ryan to Foghorn as our new CFO as we continue to advance our first-in-class pipeline," said Adrian Gottschalk, Pres

    2/23/26 7:00:00 AM ET
    $FHTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Financials

    Live finance-specific insights

    View All

    Nerdy Announces Fourth Quarter 2025 Financial Results

    Nerdy returns to year-over-year revenue growth and delivers positive non-GAAP Adjusted EBITDA in Q4 2025, beating guidance on both metrics and demonstrating significant improvement in the Company's cost structure. Nerdy completes replatforming and launch of its Live+AI™ platform using AI-native coding during the fourth quarter, providing the Company with significant momentum as we enter 2026. Nerdy Inc. (NYSE:NRDY) today announced financial results for the fourth quarter and year ended December 31, 2025. "In the fourth quarter, we returned to year-over-year revenue growth and delivered positive non-GAAP adjusted EBITDA, beating the top end of our guidance range for both metrics. We dr

    2/26/26 4:01:00 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    Nordic American Tankers Ltd (NYSE: NAT) – Report as per December 31, 2025 – Full speed ahead

      Thursday, February 26, 2026   Dear Shareholders and Investors, Ninety day periods offer a short-term snapshot. A more meaningful analysis must contain a longer-term picture. The direction of NAT is up. A few days ago, we entered into a 1-year fixed contract with an oil major, giving us more than $50,000 per day. Highlights:            The dividend for the fourth quarter 2025 is 17 cents ($0.17) per share. This is our 114th consecutive quarterly cash dividend. The dividend is payable March 24, 2026, to shareholders on record as of March 10, 2026.   The market is very solid for our ships. Nearly two-thirds of our spot days in 1Q26 have been booked at about $55,000 per day. At this s

    2/26/26 6:39:33 AM ET
    $NAT
    Marine Transportation
    Consumer Discretionary

    ATRenew to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026

    SHANGHAI, Feb. 25, 2026 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE:RERE), a pioneer in the technology-driven trade-in solutions and circular economy for consumer products in China, today announced that it plans to release its unaudited financial results for the fourth quarter and full year of 2025 before the U.S. market opens on Wednesday, March 11, 2026. The Company's management will hold an earnings conference call at 08:00 A.M. Eastern Time on Wednesday, March 11, 2026 (08:00 P.M. Beijing Time on the same day) to discuss the financial results. Listeners may access the call by dialing the following numbers:International:1-412-317-6061United States Toll Free:1-888-317-6

    2/25/26 3:00:00 AM ET
    $RERE
    Other Specialty Stores
    Consumer Discretionary

    $ADGI
    $AEMD
    $ALLR
    $ATHX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Nerdy Inc.

    SC 13D/A - Nerdy Inc. (0001819404) (Subject)

    12/4/24 4:01:10 PM ET
    $NRDY
    Other Consumer Services
    Real Estate

    SEC Form SC 13D filed by Sonder Holdings Inc.

    SC 13D - Sonder Holdings Inc. (0001819395) (Subject)

    11/27/24 4:15:36 PM ET
    $SOND
    Hotels/Resorts
    Consumer Discretionary